Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily

NCT01121809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection
HIV Infections

Interventions

DRUG: Raltegravir
DRUG: Etravirine

Sponsor

Hospitales Universitarios Virgen del Rocío